(Q53111697)

11 May 2018

title

Association of pre-transplantation positron emission tomography/computed tomography and outcome in mantle cell lymphoma. (English)

1 reference

11 May 2018

1 reference

13

K A Blum

1 reference

11 May 2018

author name string

J B Cohen

1

1 reference

11 May 2018

N C Hall

2

1 reference

11 May 2018

A S Ruppert

3

1 reference

11 May 2018

J A Jones

4

1 reference

11 May 2018

P Porcu

5

1 reference

11 May 2018

R Baiocchi

6

1 reference

11 May 2018

B A Christian

7

1 reference

11 May 2018

S Penza

8

1 reference

11 May 2018

D M Benson

9

1 reference

11 May 2018

J Flynn

10

1 reference

11 May 2018

L A Andritsos

11

1 reference

11 May 2018

S M Devine

12

1 reference

11 May 2018

language of work or name

English

0 references

publication date

15 April 2013

1 reference

11 May 2018

Bone Marrow Transplantation

published in

1 reference

11 May 2018

volume

48

1 reference

11 May 2018

issue

9

1 reference

11 May 2018

page(s)

1212-1217

1 reference

11 May 2018

https://scigraph.springernature.com/pub.10.1038/bmt.2013.46

exact match

0 references

cites work

How I treat mantle cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.46

Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: res

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.46

Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the Eur

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.46

Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.46

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.46

Mantle cell lymphoma international prognostic index but not pretransplantation induction regimen predicts survival for patients with mantle-cell lymphoma receiving high-dose therapy and autologous stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.46

The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.46

Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.46

Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.46

Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.46

Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.46

Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.46

Positron emission tomography in mantle cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.46

Post-treatment (not interim) positron emission tomography-computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R-HyperCVAD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.46

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.46

Revised response criteria for malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.46

Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.46

Report on the Second International Workshop on interim positron emission tomography in lymphoma held in Menton, France, 8-9 April 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.46

Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.46

21 January 2018

Identifiers

DOI

10.1038/BMT.2013.46

1 reference

11 May 2018

Dimensions Publication ID

1002123214

0 references

1 reference

11 May 2018